Tetra Pharm Technologies concludes preclinical testing of TPT0301 in preparation of First-in-Human clinical trials
(Adnkronos) – COPENHAGEN, Denmark, Sept. 6, 2023 /PRNewswire/ — Following convincing results from a recent In-Vitro study, the Danish biotech company, Tetra Pharm Technologies, today announces successful In-Vivo study results of its candidate compound,
